| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/28/1999 | WO1998049333A3 Eukaryotic gene expression cassette and uses thereof |
| 01/28/1999 | WO1998038324A3 Chimeric cell-surface receptors that undergo antigen-induced association |
| 01/28/1999 | CA2297103A1 Isolated dna encoding human calcium activated potassium channel |
| 01/28/1999 | CA2296762A1 Interleukin-20 |
| 01/28/1999 | CA2296736A1 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
| 01/28/1999 | CA2296530A1 Adipocyte-specific protein homologs |
| 01/28/1999 | CA2296442A1 Hiv-1 group o antigens and uses thereof |
| 01/28/1999 | CA2296319A1 Lentiviral vectors |
| 01/28/1999 | CA2296089A1 Nucleic acid vaccines encoding g protein of respiratory syncytial virus |
| 01/28/1999 | CA2295926A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells |
| 01/28/1999 | CA2295719A1 Trail receptor |
| 01/28/1999 | CA2294934A1 Gene therapy vehicle comprising dermal sheath tissue |
| 01/28/1999 | CA2237155A1 A yak-1 related serine/threonine protein kinase-htlar33 |
| 01/27/1999 | EP0893507A1 Use of MHC class II ligands (CD4 and LAG-3) as adjuvant for vaccination and of LAG-3 in cancer treatment |
| 01/27/1999 | EP0893503A2 Regulator protein from Staphylococcus aureus |
| 01/27/1999 | EP0893502A2 GreA from Staphylococcus aureus |
| 01/27/1999 | EP0893501A2 Ferrichrome transport atp-binding protein |
| 01/27/1999 | EP0893500A2 BmrU gene from Staphylococcus aureus |
| 01/27/1999 | EP0893499A2 Tetracycline resistance protein from Staphylococcus aureus |
| 01/27/1999 | EP0893498A2 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor |
| 01/27/1999 | EP0893496A2 Histidyl tRNA synthetase from Chlamydia trachomatis |
| 01/27/1999 | EP0893495A2 Isoleucyl tRNA synthetase from Chlamydia trachomatis |
| 01/27/1999 | EP0893494A2 Aspartyl tRNA synthetase from Chlamydia trachomatis |
| 01/27/1999 | EP0893493A2 Genetically modified cells and their use for prophylaxis or treatment of diseases |
| 01/27/1999 | EP0892852A2 Cytochrome p450 transducing retroviral vectors |
| 01/27/1999 | EP0892849A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 01/27/1999 | EP0892809A1 Fhit proteins and nucleic acids and methods based thereon |
| 01/27/1999 | EP0892644A1 $i(IN VIVO) GENE TRANSFER METHODS FOR WOUND HEALING |
| 01/27/1999 | CN1206458A Ceramic packing with channels for thermal and catalytic beds |
| 01/27/1999 | CN1206044A Genetically modified cells and their use in prophylaxis or therapy of disorders |
| 01/26/1999 | US5864031 Process for preparing 5-dithio-modified oligonucleotides |
| 01/26/1999 | US5864028 Degradation resistant mRNA derivatives linked to TNF-α ribozymes |
| 01/26/1999 | US5864015 Hodgkin's disease associated molecules |
| 01/26/1999 | US5863904 Methods for treating cancers and restenosis with P21 |
| 01/26/1999 | US5863797 Gene fusion encoding a hypersecretor protein |
| 01/26/1999 | US5863781 Treating or preventing conditions in which high levels of phosphotyrosine occur, such as malignancies |
| 01/26/1999 | US5863780 A polynucleotide sequence encodes human protein kinase polypeptide; culture product |
| 01/26/1999 | US5863777 DNA encoding alanyl tRNA synthetase from streptococcus pneumonine |
| 01/26/1999 | US5863770 Stable meterologous propagation of CFTR protein variant cDNA |
| 01/26/1999 | US5863769 DNA encoding interleukin-1 receptor antagonist (IL-1raβ) |
| 01/26/1999 | US5863757 An expression vector comprising polynucleotide having an open reading frame operably linked to a promoter and encoding a specific polypeptide |
| 01/26/1999 | US5863541 Proteins in cells |
| 01/25/1999 | CA2238664A1 Novel regulator |
| 01/25/1999 | CA2238655A1 Cdna clone my1 that encodes a novel human 7-transmembrane receptor |
| 01/24/1999 | CA2238658A1 Novel grea |
| 01/23/1999 | CA2238682A1 Novel asps |
| 01/23/1999 | CA2238679A1 Novel phes |
| 01/23/1999 | CA2238677A1 Novel iles |
| 01/23/1999 | CA2238674A1 Novel tetracycline resistance protein |
| 01/23/1999 | CA2238671A1 Novel bmru |
| 01/23/1999 | CA2238667A1 Novel ferrichrome transport atp-binding protein |
| 01/23/1999 | CA2238665A1 Novel reductase |
| 01/23/1999 | CA2238663A1 Novel hiss |
| 01/23/1999 | CA2238611A1 Novel lyss |
| 01/23/1999 | CA2238608A1 Novel cyss |
| 01/23/1999 | CA2211293A1 Recombinant lysostaphin analogs |
| 01/21/1999 | WO1999002989A1 Chaperone fragments |
| 01/21/1999 | WO1999002732A1 Antisense oligonucleotide inhibition of ras |
| 01/21/1999 | WO1999002715A1 SPLICE VARIANTS OF BRCA1 AND $i(BRCA2) |
| 01/21/1999 | WO1999002713A1 Pseudomonas exotoxin a-like chimeric immunogens |
| 01/21/1999 | WO1999002701A1 Pak kinase genes and polypeptides and methods of use thereof |
| 01/21/1999 | WO1999002696A1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 01/21/1999 | WO1999002694A1 Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue |
| 01/21/1999 | WO1999002686A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof |
| 01/21/1999 | WO1999002685A1 Interleukin-3 gene therapy for cancer |
| 01/21/1999 | WO1999002683A1 Modified lepidopteran receptors and hybrid multifunctional proteins for use in regulation of transgene expression |
| 01/21/1999 | WO1999002681A1 Erbb4 receptor-specific neuregulin, related ligands and uses thereof |
| 01/21/1999 | WO1999002667A1 Mutations in the myostation gene cause double-muscling in mammals |
| 01/21/1999 | WO1999002647A2 Cloning vectors for producing adenoviral minimal viruses |
| 01/21/1999 | WO1999002561A1 Human f11 antigen: a cell surface receptor involved in platelet aggregation |
| 01/21/1999 | WO1999002550A1 Ctl epitopes from ebv |
| 01/21/1999 | WO1999002547A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 01/21/1999 | WO1999002545A2 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 01/21/1999 | WO1999002192A1 Method of inducing apoptosis by reducing the level of thiamin |
| 01/21/1999 | WO1999002191A1 Compositions and methods for enhancing delivery of therapeutic agents to cells |
| 01/21/1999 | WO1999002190A1 Organ-specific targeting of cationic amphiphile/retinoblastoma encoding dna complexes for gene therapy |
| 01/21/1999 | WO1999002179A1 Axin gene and uses thereof |
| 01/21/1999 | WO1999002171A1 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 01/21/1999 | WO1999002167A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 01/21/1999 | WO1999002132A2 Use of submicron oil-in-water emulsions with dna vaccines |
| 01/21/1999 | WO1998048025A3 Regulatory system for inducible expression of genes with lambdoid promoters |
| 01/21/1999 | WO1998046781A3 Novel transgene expression system for increased persistence |
| 01/21/1999 | WO1998046273A3 Delivery system for gene therapy to the brain |
| 01/21/1999 | WO1998024810A3 Vertebrate homologues of unc-53 protein of c. elegans |
| 01/21/1999 | CA2332636A1 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 01/21/1999 | CA2298834A1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 01/21/1999 | CA2296434A1 Mutations in the myostatin gene cause double-muscling in mammals |
| 01/21/1999 | CA2296093A1 Modified lepidopteran receptors and hybrid multifunctional proteins for use in regulation of transgene expression |
| 01/21/1999 | CA2295740A1 Use of submicron oil-in-water emulsions with dna vaccines |
| 01/21/1999 | CA2295539A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof |
| 01/21/1999 | CA2295375A1 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 01/21/1999 | CA2294752A1 Pak kinase genes and polypeptides and methods of use thereof |
| 01/21/1999 | CA2294732A1 Ctl epitopes from ebv |
| 01/21/1999 | CA2290736A1 Interleukin-3 gene therapy for cancer |
| 01/21/1999 | CA2290038A1 Chaperone fragments |
| 01/21/1999 | CA2237698A1 Genetically modified cells and their use in the prophylaxis or therapy of disorders |
| 01/20/1999 | EP0892063A2 Histidine kinase |
| 01/20/1999 | EP0892062A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC |
| 01/20/1999 | EP0892061A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratB |
| 01/20/1999 | EP0892060A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratA |